SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer’s Disease Biomarkers

Dan Yu,1,2,* Qilong Yin,1,3,* Jiwei Wang,1,* Jian Yang,1 Zimeng Chen,1 Zihan Gao,1 Qingli Huang,1,4 Shibao Li1,3 1Medical Technology School of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China; 2Jiangsu Key Laboratory of Medical Science and Laboratory Medicine,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu D, Yin Q, Wang J, Yang J, Chen Z, Gao Z, Huang Q, Li S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/1d8331da151a41e69e157ebf55fb9b30
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1d8331da151a41e69e157ebf55fb9b30
record_format dspace
spelling oai:doaj.org-article:1d8331da151a41e69e157ebf55fb9b302021-12-02T13:58:32ZSERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer’s Disease Biomarkers1178-2013https://doaj.org/article/1d8331da151a41e69e157ebf55fb9b302021-03-01T00:00:00Zhttps://www.dovepress.com/sers-based-immunoassay-enhanced-with-silver-probe-for-selective-separa-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Dan Yu,1,2,* Qilong Yin,1,3,* Jiwei Wang,1,* Jian Yang,1 Zimeng Chen,1 Zihan Gao,1 Qingli Huang,1,4 Shibao Li1,3 1Medical Technology School of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China; 2Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, 212013, People’s Republic of China; 3Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China; 4Public Experimental Research of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qingli HuangPublic Experimental Research of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of ChinaTel +86 15150043097Fax +86 516 83262091Email qlhuang@xzhmu.edu.cnShibao LiDepartment of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of ChinaTel +86 15895212960Fax +86 516 83353651Email sdjnshlb@xzhmu.edu.cnPurpose: Developing a sensitive SERS-based method to quantitatively detect serum biomarkers (Aβ 1-42 and P-Tau-181) for the early diagnosis of Alzheimer’s disease (AD).Methods: In this study, a novel SERS-based sandwich immunoassay, which consists of tannin-capped silver nanoparticles and magnetic graphene oxide (Fe3O4@GOs), was developed. We firstly applied this method for the detection of protein standards in buffer solution, obtaining the regression equation. Then, its potential value on real serum samples of AD was further explored.Results: The detection linear range of Aβ 1-42 and P-Tau-181 protein standards were observed to range from 100 pg mL− 1 to 10 fg mL− 1, 100 pg mL− 1 to 1 fg mL− 1 respectively. We finally explored clinical application of the proposed method in 63 serum samples. As a result, P-tau-181 differentiated AD from non-AD dementia patients (AUC = 0.770), with a more favored ROC than Aβ 1-42 (AUC =  0.383).Conclusion: The developed SERS-based immunoassay is successfully applied to the determination of Aβ 1-42 and P-Tau-181 in human serum specimens, which provides a promising tool for the early diagnosis of AD.Keywords: surface-enhanced Raman scattering, silver probe, Alzheimer’s disease, biomarker, diagnosisYu DYin QWang JYang JChen ZGao ZHuang QLi SDove Medical Pressarticlesurface-enhanced raman scatteringsilver probealzheimer’ s diseasebiomarkerdiagnosisMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 1901-1911 (2021)
institution DOAJ
collection DOAJ
language EN
topic surface-enhanced raman scattering
silver probe
alzheimer’ s disease
biomarker
diagnosis
Medicine (General)
R5-920
spellingShingle surface-enhanced raman scattering
silver probe
alzheimer’ s disease
biomarker
diagnosis
Medicine (General)
R5-920
Yu D
Yin Q
Wang J
Yang J
Chen Z
Gao Z
Huang Q
Li S
SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer’s Disease Biomarkers
description Dan Yu,1,2,* Qilong Yin,1,3,* Jiwei Wang,1,* Jian Yang,1 Zimeng Chen,1 Zihan Gao,1 Qingli Huang,1,4 Shibao Li1,3 1Medical Technology School of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China; 2Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, 212013, People’s Republic of China; 3Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China; 4Public Experimental Research of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qingli HuangPublic Experimental Research of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of ChinaTel +86 15150043097Fax +86 516 83262091Email qlhuang@xzhmu.edu.cnShibao LiDepartment of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of ChinaTel +86 15895212960Fax +86 516 83353651Email sdjnshlb@xzhmu.edu.cnPurpose: Developing a sensitive SERS-based method to quantitatively detect serum biomarkers (Aβ 1-42 and P-Tau-181) for the early diagnosis of Alzheimer’s disease (AD).Methods: In this study, a novel SERS-based sandwich immunoassay, which consists of tannin-capped silver nanoparticles and magnetic graphene oxide (Fe3O4@GOs), was developed. We firstly applied this method for the detection of protein standards in buffer solution, obtaining the regression equation. Then, its potential value on real serum samples of AD was further explored.Results: The detection linear range of Aβ 1-42 and P-Tau-181 protein standards were observed to range from 100 pg mL− 1 to 10 fg mL− 1, 100 pg mL− 1 to 1 fg mL− 1 respectively. We finally explored clinical application of the proposed method in 63 serum samples. As a result, P-tau-181 differentiated AD from non-AD dementia patients (AUC = 0.770), with a more favored ROC than Aβ 1-42 (AUC =  0.383).Conclusion: The developed SERS-based immunoassay is successfully applied to the determination of Aβ 1-42 and P-Tau-181 in human serum specimens, which provides a promising tool for the early diagnosis of AD.Keywords: surface-enhanced Raman scattering, silver probe, Alzheimer’s disease, biomarker, diagnosis
format article
author Yu D
Yin Q
Wang J
Yang J
Chen Z
Gao Z
Huang Q
Li S
author_facet Yu D
Yin Q
Wang J
Yang J
Chen Z
Gao Z
Huang Q
Li S
author_sort Yu D
title SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer’s Disease Biomarkers
title_short SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer’s Disease Biomarkers
title_full SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer’s Disease Biomarkers
title_fullStr SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer’s Disease Biomarkers
title_full_unstemmed SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer’s Disease Biomarkers
title_sort sers-based immunoassay enhanced with silver probe for selective separation and detection of alzheimer’s disease biomarkers
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/1d8331da151a41e69e157ebf55fb9b30
work_keys_str_mv AT yud sersbasedimmunoassayenhancedwithsilverprobeforselectiveseparationanddetectionofalzheimerrsquosdiseasebiomarkers
AT yinq sersbasedimmunoassayenhancedwithsilverprobeforselectiveseparationanddetectionofalzheimerrsquosdiseasebiomarkers
AT wangj sersbasedimmunoassayenhancedwithsilverprobeforselectiveseparationanddetectionofalzheimerrsquosdiseasebiomarkers
AT yangj sersbasedimmunoassayenhancedwithsilverprobeforselectiveseparationanddetectionofalzheimerrsquosdiseasebiomarkers
AT chenz sersbasedimmunoassayenhancedwithsilverprobeforselectiveseparationanddetectionofalzheimerrsquosdiseasebiomarkers
AT gaoz sersbasedimmunoassayenhancedwithsilverprobeforselectiveseparationanddetectionofalzheimerrsquosdiseasebiomarkers
AT huangq sersbasedimmunoassayenhancedwithsilverprobeforselectiveseparationanddetectionofalzheimerrsquosdiseasebiomarkers
AT lis sersbasedimmunoassayenhancedwithsilverprobeforselectiveseparationanddetectionofalzheimerrsquosdiseasebiomarkers
_version_ 1718392185190088704